CD138
CD138
₪486.00 – ₪2,262.00
Cluster of differentiation 138 (CD138), also known as Syndecan-1, is a transmembrane glycoprotein present on the surface of B-cells during late stage differentiation. Anti-CD138 is used to differentiate marginal zone lymphoma from lymphoplasmacytic lymphoma. ALK+ Large B-Cell Lymphoma (LBCL) commonly stains positively for CD138, but not for CD20 and CD79a. Anti-CD138 reacts positively with HHV8-associated primary effusion lymphoma that lack B-cell markers. CD138 is also a useful marker for identifying and enumerating benign, reactive, or malignant plasma cells from the bone marrow biopsy samples.
| Image | Variation | SKU | Price | Quantity | Add To Cart |
|---|---|---|---|---|---|
 |
0.1ml - | IHC138-100 | ₪486.00 | |
Add to cart |
|
|
1ml - | IHC138-1 | ₪2,262.00 | |
Add to cart |
|
|
Positive Control 3 Slides - | IHC138-PC | ₪553.00 | |
Add to cart |
Description
CE-IVD registered and supplied as a concentrate.
Specifications
| Clone | IHC138 |
| Source | Mouse Monoclonal |
| Positive Control | Tonsil |
| Dilution Range | 1:100 – 1:200 |
References
- Chilosi M, et al. Mod Pathol. 1999; 12:1101-6.
- Sebestyén A, et al. Br J Haematol. 1999; 104:412-9.
- Bayer-Garner IB, et al. Mod Pathol. 2001; 14:1052-8.
- Said J, et al. WHO Press, Geneva, Switzerland. 261.
- O’Connell FP, et al. Am J Clin Pathol. 2004; 121:254-63.
- Colomo L, et al. Am J Surg Pathol. 2004; 28:736-47.
- Carbone A, et al. Blood. 1998; 91:747-55.
Additional information
| Unit | 0.1ml, 1ml, Positive Control 3 slides |
|---|
